• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Search Results for: side event

Enforcement, Creative R&D Financing Priority Issues For Public Health in 2009

25/02/2009 by Kaitlin Mara for Intellectual Property Watch Leave a Comment

The number and intensity of debates over the role of intellectual property rights in public health is set to increase in 2009.

New leadership and new mandates for key intergovernmental organisations implemented last year have created opportunity for change. And while old debates over the balance between IP rights and access to health products are not going away, this year will see more exploration at the intergovernmental level of different systems to stimulate innovation.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Access to Knowledge/ Education, Enforcement, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO

Industry Pushes For Biosimilars Approval Process; Some IGOs Take Notice

24/02/2009 by Kiernan A. Murphy for Intellectual Property Watch and Kaitlin Mara for Intellectual Property Watch Leave a Comment

Key players in the biotechnology industry are leading an effort to obtain global approval processes for generic biological medicines, which experts say could provide cheaper access to costly but widely prescribed and promising treatments.

Filed Under: Features, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Biodiversity/Genetic Resources/Biotech, English, Europe, Health & IP, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, WHO

French Legislature Puts Finishing Touches On Ambitious File-Sharing Law

23/02/2009 by Bruce Gain for Intellectual Property Watch 5 Comments

French legislators are putting the final touches on controversial legislation that will likely lead to the most governmentally-proactive law intended to curb illegal file sharing among any other European Union member state.

Filed Under: Features, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, Enforcement, English, Europe, Information and Communications Technology/ Broadcasting

ISP Liability, Copyright Term Extension Key IP Issues For Europe This Year

18/02/2009 by Dugie Standeford for Intellectual Property Watch Leave a Comment

The effort to tackle digital piracy is likely to remain the most contentious intellectual property issue in Europe this year. It will be joined by debates on copyright term extension, IP provisions in trade agreements, and an ongoing discussion of patent policy in Europe.

Filed Under: IP Policies, Subscribers, Themes, Venues, Copyright Policy, Enforcement, English, Europe, Patents/Designs/Trade Secrets

Strong EU Trade Provisions On IP Seen As Threat To Poor Nations’ Medicines Access

18/02/2009 by David Cronin for Intellectual Property Watch 2 Comments

BRUSSELS – Efforts by the European Union to insert strong provisions on pharmaceutical patents in a series of free trade agreements it is negotiating could imperil access to medicines in developing countries, global public health activists have alleged.

As part of trade talks being conducted with India, Colombia, Peru and a regional grouping in south-east Asia, EU officials have proposed that drug-makers should benefit from a robust intellectual property regime. National regulatory authorities in the countries concerned would be prevented for lengthy periods from using data provided by a company that holds a drug patent in order to authorise a generic version of that medicine.

Filed Under: IP Policies, Language, News, Themes, Venues, Asia/Pacific, Bilateral/Regional Negotiations, Enforcement, English, Europe, Health & IP, Human Rights, Latin America/Caribbean, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WTO/TRIPS

Internet Governance Policy In 2009: Transition To New Digital Oversight

12/02/2009 by Monika Ermert for Intellectual Property Watch Leave a Comment

This year could be a transitional one for global internet governance policy, as the internet’s technical oversight body may finally lose its ties to the United States, the next generation internet comes into its own, the UN Internet Governance Forum will be reviewed, and the world could see the rapid spread of new internet domains.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, ITU/ICANN, Information and Communications Technology/ Broadcasting, North America

Sports Federations Keep Up Defence Against Possible IP Infringers

12/02/2009 by Catherine Saez, Intellectual Property Watch Leave a Comment

Constant vigilance is needed to protect intellectual property rights in sports from creative efforts by “ambush marketers” and others seeking to take unauthorised advantage of sports events, event organisers say.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Copyright Policy, Enforcement, English, Information and Communications Technology/ Broadcasting, Trademarks/Geographical Indications/Domains

Proponents Explore Designs For Prizes To Aid Neglected Disease Research

12/02/2009 by Kaitlin Mara for Intellectual Property Watch 2 Comments

The World Health Organization global strategy on public health, innovation and intellectual property calls for the exploration of alternative mechanisms to incentivise research and development, including the use of prize funds. A diverse group of non-governmental agencies, government and pharmaceutical industry representatives recently looked at prize funds in detail, to determine different possible approaches and where they might best be applied to medical innovations.

Filed Under: Features, IP Policies, Themes, Venues, Development, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO

US Transition: Latest IP News

Official Technology & Innovation Platform: Obama/Biden 23 October Kappos’ Early Days At USPTO: Many Changes, Few Funds 3 September Punke Nominated As WTO Ambassador; Stoll To Succeed Doll As US Patent Commissioner 29 July USPTO Nominee Kappos Appears To Clear First Senate Hurdle 29 July Rumoured New US Ambassador To UN In Geneva A Major […]

About Us

Contact — Mission — Funding — Governance CONTACT Intellectual Property Watch CP 2100 1-5, route des Morillons 1211 Geneva 2 Switzerland Phone: +41 (0)22 791 67 16 Fax: +41 (0)22 791 66 35 Email: info@ip-watch.org MISSION Intellectual Property Watch is a non-profit independent news service that provides professional coverage of global policymaking on intellectual property and innovation. […]

  • « Previous Page
  • 1
  • …
  • 188
  • 189
  • 190
  • 191
  • 192
  • …
  • 229
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2026 · Global Policy Reporting